Why the study?
The study was conducted to develop a risk model for sudden cardiac death in high-risk acute myocardial infarction survivors.
Population
13 202 high-risk AMI survivors from CAPRICORN and VALIANT with validation in EPHESUS
Design
Risk model derivation and validation study
Follow-up
Median 2.0 years
Authors
Loading...
May aid post-AMI SCD risk stratification; leaves open prospective validation before clinical use.
An 11-variable clinical risk score predicts sudden cardiac death in high-risk acute myocardial infarction survivors significantly better than left ventricular ejection fraction alone.
Docherty et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: